Novel Antigenic Targets of HPV Therapeutic Vaccines
Human papillomavirus (HPV) infection is the cause of the majority of cervical cancers and head and neck cancers worldwide. Although prophylactic vaccines and cervical cancer screening programs have shown efficacy in preventing HPV-associated cervical cancer, cervical cancer is still a major cause of...
Guardado en:
Autores principales: | Ditte Rahbæk Boilesen, Karen Nørgaard Nielsen, Peter Johannes Holst |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/86f668f39411417a8880bbb18c185db9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacists’ Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature Review
por: Oluwafemifola Oyedeji, et al.
Publicado: (2021) -
Perceptions of HPV vaccination and pharmacist-physician collaboration models to improve HPV vaccination rates
por: Benjamin S. Teeter, et al.
Publicado: (2021) -
Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart Immunotherapy
por: Noha M. Hammad, et al.
Publicado: (2021) -
Treatment Following Erythema Multiforme in the Oral Mucosa After qHPV Vaccine with Low-Level Laser Therapy: Case Report
por: Magalhães,Amanda de Paula, et al.
Publicado: (2021) -
REGIONAL VACCINATION PROGRAM FOR THE PREVENTION OF HPV-ASSOCIATED DISEASES IN THE KHMAO-YUGRA
por: L. D. Belotsercovtseva, et al.
Publicado: (2014)